02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1144 15 783 77 937 163 992
ERLYTX 77 0 0 4 49 11 67
GI 168 1 52 13 158 22 134
GU 379 12 626 50 609 82 499
LEUK 167 4 209 15 183 30 183
LUNG 207 4 209 15 183 36 219
LYMPH 431 5 261 32 390 68 414
MELAN 9 0 0 0 0 4 24
MMYEL 110 0 0 5 61 16 97
MULT 50 0 0 0 0 6 37
OTHER 52 0 0 2 24 5 30
Total 2794 41 2140 213 2594 443 2696

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 201 4 209 20 244 41 250
ERLYTX 4 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 7 1 52 1 12 2 12
LEUK 618 11 574 55 670 104 633
LUNG 368 4 209 26 317 54 329
OTHER 14 1 52 4 49 5 30
PEOLC 84 0 0 1 12 5 30
PREV 235 1 52 10 122 21 128
SXQOL 663 14 730 56 682 122 743
Total 2195 36 1878 174 2120 355 2161

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1144 15 783 77 937 163 992
CCD 201 4 209 20 244 41 250
ERLYTX 81 0 0 4 49 11 67
GI 169 1 52 14 170 23 140
GU 386 13 678 51 621 84 511
LEUK 785 15 783 70 852 134 816
LUNG 575 8 417 41 499 90 548
LYMPH 431 5 261 32 390 68 414
MELAN 9 0 0 0 0 4 24
MMYEL 110 0 0 5 61 16 97
MULT 50 0 0 0 0 6 37
OTHER 66 1 52 6 73 10 61
PEOLC 84 0 0 1 12 5 30
PREV 235 1 52 10 122 21 128
SXQOL 663 14 730 56 682 122 743
Total 4989 77 4017 387 4712 798 4858

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 705 7 365 37 450 90 548
ERLYTX 53 0 0 2 24 9 55
GI 128 1 52 12 146 20 122
GU 287 9 470 34 414 58 353
LEUK 103 2 104 8 97 19 116
LUNG 131 4 209 12 146 25 152
LYMPH 280 3 157 21 256 43 262
MELAN 8 0 0 0 0 4 24
MMYEL 62 0 0 2 24 11 67
MULT 19 0 0 0 0 3 18
OTHER 52 0 0 2 24 5 30
Total 1828 26 1357 130 1581 287 1747

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 148 4 209 14 170 27 164
ERLYTX 4 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 7 1 52 1 12 2 12
LEUK 255 4 209 20 244 40 244
LUNG 225 3 157 17 207 36 219
OTHER 14 1 52 4 49 5 30
PEOLC 69 0 0 1 12 5 30
PREV 235 1 52 10 122 21 128
SXQOL 492 11 574 46 560 96 584
Total 1450 25 1305 114 1388 233 1417

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 894 13 678 59 718 131 797
CCD 172 3 157 16 195 23 140
ERLYTX 57 0 0 2 24 9 55
GI 138 4 209 16 195 24 146
GU 328 10 522 44 536 73 444
LEUK 361 6 313 30 365 61 371
LUNG 386 13 678 36 438 71 432
LYMPH 280 3 157 21 256 43 262
MELAN 8 0 0 0 0 4 24
MMYEL 62 0 0 2 24 11 67
MULT 45 2 104 5 61 9 55
OTHER 145 1 52 6 73 11 67
PEOLC 69 0 0 0 0 5 30
PREV 235 1 52 10 122 21 128
SXQOL 492 11 574 46 560 96 584
Total 3672 67 3496 293 3567 592 3602

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 972 13 678 70 852 151 919
ERLYTX 72 0 0 4 49 11 67
GI 98 0 0 7 85 10 61
GU 269 8 417 37 450 60 365
LEUK 136 3 157 12 146 26 158
LUNG 181 4 209 14 170 32 195
LYMPH 352 4 209 22 268 51 310
MMYEL 96 0 0 5 61 13 79
MULT 50 0 0 0 0 6 37
Total 2226 32 1670 171 2081 360 2191

02-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1922 27 1409 144 1753 295 1796
AFFIL 133 2 104 4 49 11 67
CCOP/NCORP 1223 22 1148 96 1169 214 1303
Non-SWOG 1711 26 1357 143 1741 278 1692
Total 4989 77 4018 387 4712 798 4858

02-SEP-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 1 Y 18-AUG-26
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 2 Y 18-AUG-26
LYMPH S2506 NHL, R/R MZL, Mozun +/- Zanu or Pola 1 Y 18-AUG-26
LUNG S1900N AGAs: SG alone, I alone, or SG + I 1 Y 03-AUG-26

02-SEP-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 27-AUG-26
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 N 15-AUG-26
LUNG A082002 Lung, Adv, Systemic Tx +/- SBRT 1 E 14-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 1 E 07-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 2 E 07-AUG-26
LUNG S2402 NSCLC, All Stg, Periop Vs Adj Tx 1 E 07-AUG-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 0 E 03-AUG-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 1 E 03-AUG-26

02-SEP-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 16
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 10
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 10
LUNG LUNGMAP NSCLC, Adv, Master 2 7
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 7
LUNG LUNGMAP NSCLC, Adv, Master 1 4
GI NRGGI008 Colon, Stg III, Adj Chemo 1 3
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3